Modified Herpes Virus to Be Tested in Sarcoma Patients
March 9th 2011The FDA has awarded a $600,000 grant for a phase I clinical trial of a genetically reprogrammed herpes simplex virus in young cancer patients with relapsed non-central nervous system (CNS) solid tumors such as sarcomas and neuroblastomas.
Read More
Lung Cancer Screening Test Raises Hopes and Sets Stage for Discussion of Guidelines
March 9th 2011Lung Cancer Screening Test Raises Hopes and Sets Stage for Discussion of Guidelines The Lung Cancer Alliance is pressing for a full discussion about the guidance on whether people at high risk for lung cancer should undergo screening
Read More
NCCN Launches Consumer-Friendly Versions
March 9th 2011NCCN Launches Consumer-Friendly Versions of Guideline Publications Breast cancer and non-small cell lung cancer are the inaugural entries in a new series of publications the National Comprehensive Cancer Network (NCCN) is rolling out in the coming months.
Read More
FDA Approves Denosumab to Fight Cancer Bone Injuries
March 9th 2011Denosumab, a monoclonal antibody that has proved effective in preventing bone fractures and bone pain for patients whose cancer has metastasized and damaged the bone, won approval from the FDA after a 6-month priority review.
Read More